0DKX Stock Overview
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 1/6 |
Dividends | 6/6 |
Rewards
Risk Analysis
Aedifica NV/SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €61.20 |
52 Week High | €76.50 |
52 Week Low | €47.18 |
Beta | 0.83 |
1 Month Change | 8.32% |
3 Month Change | 3.18% |
1 Year Change | -19.79% |
3 Year Change | -41.12% |
5 Year Change | -25.64% |
Change since IPO | 58.55% |
Recent News & Updates
Recent updates
Shareholder Returns
0DKX | GB Health Care REITs | GB Market | |
---|---|---|---|
7D | 1.6% | 2.4% | 1.3% |
1Y | -19.8% | -13.6% | 3.5% |
Return vs Industry: 0DKX underperformed the UK Health Care REITs industry which returned -13.6% over the past year.
Return vs Market: 0DKX underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
0DKX volatility | |
---|---|
0DKX Average Weekly Movement | 2.9% |
Health Care REITs Industry Average Movement | 2.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0DKX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0DKX's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 127 | Mrics Gielens | www.aedifica.eu |
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 620 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden, Ireland and Spain, worth more than €5.8 billion.
Aedifica NV/SA Fundamentals Summary
0DKX fundamental statistics | |
---|---|
Market cap | €2.96b |
Earnings (TTM) | €84.03m |
Revenue (TTM) | €326.75m |
35.2x
P/E Ratio9.0x
P/S RatioIs 0DKX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0DKX income statement (TTM) | |
---|---|
Revenue | €326.75m |
Cost of Revenue | €18.58m |
Gross Profit | €308.17m |
Other Expenses | €224.13m |
Earnings | €84.03m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
Earnings per share (EPS) | 1.77 |
Gross Margin | 94.31% |
Net Profit Margin | 25.72% |
Debt/Equity Ratio | 63.6% |
How did 0DKX perform over the long term?
See historical performance and comparisonDividends
6.3%
Current Dividend Yield51%
Payout RatioDoes 0DKX pay a reliable dividends?
See 0DKX dividend history and benchmarksAedifica/SA dividend dates | |
---|---|
Ex Dividend Date | May 16 2024 |
Dividend Pay Date | May 22 2024 |
Days until Ex dividend | 12 days |
Days until Dividend pay date | 18 days |
Does 0DKX pay a reliable dividends?
See 0DKX dividend history and benchmarks